Proteomic analysis on the antibacterial activity of a Ru(II) complex against Streptococcus pneumoniae
- 1 February 2015
- journal article
- Published by Elsevier in Journal of Proteomics
- Vol. 115, 107-116
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21271086, 31000373)
- Guangdong Natural Science Research (32213027, S2012010008685)
- Pearl River Rising Star of Science and Technology of Guangzhou City (2011J2200003)
This publication has 31 references indexed in Scilit:
- A Molecular Mechanism for Bacterial Susceptibility to ZincPLOS Pathogens, 2011
- Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducersMedChemComm, 2010
- A categorization of metal anticancer compounds based on their mode of actionDalton Transactions, 2009
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation studyAnti-Cancer Drugs, 2009
- Pathogens Associated With Sepsis in Newborns and Young Infants in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- Proteomic approach to study the cytotoxicity of dioscin (saponin)Proteomics, 2006
- Metal-based antitumour drugs in the post genomic eraDalton Transactions, 2006
- Virulence factors and the pathogenesis of disease causedbyResearch in Microbiology, 2000
- Pharmacological control of lung metastases of solid tumours by a novel ruthenium complexClinical & Experimental Metastasis, 1998
- Biological Activity of Complex IonsNature, 1952